Ketamine Usage in the UK 1998-2002
1 Introduction
1.1 Ketamine
(2-(2-Chlorophenyl)-2-(methylamino)- cyclohexanone) is
one of a class of drugs known as dissociative anaesthetics,
other drugs in this class include phencyclidine (PCP/angel
dust), dextromorphan, and nitrous oxide). Ketamine is
widely used in veterinary medicine, and is not currently
a controlled drug. Tablets containing ketamine are commonly
found on the illicit market, either masquerading as ecstasy
or sold as Ketamine itself (known by devotees as special-K).
1.2 Originally
used as an animal tranquilliser, ketamine induces a trance-like
state described by some users as an out of body experience
or tunnel vision, with the user commonly sedated
or even immobilised.
1.3 Ketamine
has commonly been associated with fake ecstasy
tablets, although these are now less common. To counteract
the sedative effect, stimulants such as procaine, ephedrine,
caffeine or amphetamine are often included in Ketamine
tablets. Although tablets are now the most common form
of ketamine, it is also found in injection ampoules, bottles
or in powder form.
2 Methodology
2.1 The
IDMU regular users surveys have been monitoring changes
in patterns of drug use since 1994, and annually since
1997, in surveys with a target of 1000-3000 respondents.
In the 1994 and 1997 surveys ketamine was the most commonly-reported
other psychedelic, among other named drugs
written in by respondents, and merited inclusion in its
own right in the 1998 survey onwards.
2.2
Anonymous questionnaires were distributed at pop festivals
and other outdoor events. Other than basic demographic
information, respondents are asked a number of core questions
each year, concerning use of and attitudes to legal and
illegal drugs, with other questions, and question order,
changing year on year. For Ketamine use, the questions
were:
Age
first use of ketamine
Frequency
of/intention to use ketamine
Monthly
spending on ketamine
Overall
rating of ketamine (marks out of 10)
Ketamine
prices
In
2001-2, users were also asked how much they used per week
(doses/tabs) and when they had last used the drug.
2.3The
purpose of the surveys is to target populations expected
to contain a high proportion of drug users in order to
conduct research into the illicit drugs market. The vast
majority of respondents have used cannabis in the month
prior to the survey. In the context of Drug Misuse
Declared data, our population would be more representative
of drug users as a whole, rather than of the general population.
2.4Please
note that figures for 2001 were collected on a restricted
basis, with a more biased population (predominantly London
area), the smaller sample also giving rise to greater
statistical margin of error.
3Sample
Demographics
3.1The
overall average age of respondents was 28.03 years with
the year on year averages varying by up to a year either
way. Female respondents were on average around 9 months
younger than males. There was a 3:2 male-female ratio,
with 8% of respondents declining to state their sex (table
1), and 3.8% declining to state their age.
|
Table
1 - Age of Respondents by Sex and Year
|
|
Sex
|
Male
|
Female
|
Not
Stated
|
Totals
|
|
Year
|
n
|
Age
|
n
|
age
|
n
|
age
|
n
|
age
|
|
1998
|
629
|
29.31
|
419
|
28.81
|
80
|
28.58
|
1128
|
29.07
|
|
1999
|
1213
|
27.25
|
734
|
27.16
|
145
|
28.47
|
2092
|
27.30
|
|
2000
|
1293
|
27.22
|
743
|
26.87
|
208
|
27.98
|
2244
|
27.17
|
|
2001
|
366
|
27.52
|
219
|
26.48
|
69
|
27.12
|
654
|
27.13
|
|
2002
|
1457
|
29.84
|
1055
|
27.75
|
206
|
30.63
|
2718
|
29.09
|
|
Totals:
|
4958
|
28.28
|
3170
|
27.46
|
708
|
28.83
|
8836
|
28.03
|
|
%
|
56.1%
|
35.9%
|
8.0%
|
100.0%
|
3.2 The
age range of respondents varied from early teens to late
middle-age (fig 1), with the highest numbers in the range
of 18-30.
Fig
1-Age Range of Respondents

4 Prevalence
of Ketamine Use
4.1 In
our 1998-2002 surveys (see table 2), 1329 users (14.8%
of respondents) had tried ketamine, the vast majority
on an experimental or occasional basis, with 279 individuals
(3%) claiming to use occasionally or more often. The proportion
of users each year is relatively stable between a low
of 13.0% in 2000, and a high of 18.4% in the smaller 2001
survey. Similarly current use remains relatively
stable at 2-3%, apart from a blip in 2001.
|
Table
2 - Ketamine Use by Regular Drug Users (1998-2002)
|
|
Year
|
1998
|
1999
|
2000
|
2001
|
2002
|
1998-2002
|
|
Frequency
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
|
Non
User
|
999
|
86.6%
|
1947
|
89.6%
|
2150
|
91.4%
|
594
|
87.2%
|
2493
|
88.2%
|
8183
|
89.1%
|
|
Experimental
|
126
|
10.9%
|
169
|
7.8%
|
142
|
6.0%
|
43
|
6.3%
|
241
|
8.5%
|
721
|
7.9%
|
|
Occasional
|
21
|
1.8%
|
40
|
1.8%
|
41
|
1.7%
|
18
|
2.6%
|
43
|
1.5%
|
163
|
1.8%
|
|
Regular
|
5
|
0.4%
|
16
|
0.7%
|
16
|
0.7%
|
20
|
2.9%
|
40
|
1.4%
|
97
|
1.1%
|
|
Daily
|
2
|
0.2%
|
0
|
0.0%
|
3
|
0.1%
|
6
|
0.9%
|
8
|
0.3%
|
19
|
0.2%
|
|
Total Ever
|
189
|
16.4%
|
318
|
14.6%
|
306
|
13.0%
|
125
|
18.4%
|
421
|
14.9%
|
1359
|
14.8%
|
|
Current User
|
28
|
2.4%
|
56
|
2.6%
|
60
|
2.6%
|
44
|
6.5%
|
91
|
3.2%
|
279
|
3.0%
|
|
Base
|
1153
|
2173
|
2352
|
681
|
2825
|
9183
|
4.2 On
the basis of there being 2-3 million UK citizens using
drugs in an average month, possibly 300-500 thousand persons
will have tried ketamine, with 60-90,000 current users
(occasionally or more often).
4.3 In
2001 and 2002, respondents were asked to quantify their
ketamine use in doses or tablets per week, with a range
of 0-10 doses (fig 2)
Fig
2-Ketamine Tablets/Doses per Week

4.4
In 2001/02 users were also asked to state when they had
last used ketamine (table 3) - note the today figures
may be skewed as a result of sampling location.
|
Table
3-Most recent Ketamine use (2001-2)
|
|
Most recent use
|
number
|
Raw %
|
Cumulative %
|
|
Today
|
6
|
0.2%
|
0.2%
|
|
Past week
|
19
|
0.5%
|
0.7%
|
|
Past month
|
36
|
1.0%
|
1.7%
|
|
Past Year
|
87
|
2.5%
|
4.2%
|
|
5 years
|
122
|
3.5%
|
7.7%
|
|
Longer
|
44
|
1.3%
|
9.0%
|
|
Never
|
497
|
14.2%
|
23.1%
|
|
No response
|
2695
|
76.9%
|
100.0%
|
|
Base
|
3506
|
100.0%
|
|
4.5 A
total of 134 respondents (98-02) reported monthly spending
on ketamine, with a mean of £19.22 and a maximum of £200
(fig 3)
Fig
3-Monthly Spending on Ketamine

5 Initiation
to Ketamine Use
5.1Of
those individuals who had not used Ketamine, 2222 indicated
whether or not they intended to use the drug in the future,
289 (13%) stating they might use, and 87% stating they
would never use the drug. The proportion of non-users
willing to consider using ketamine fell from 16% in 1998
to 10% in 2002 (table 4).
|
Table
4-Intentions & Age Initiation to Ketamine
Use & User Ratings
|
|
Year
|
1998
|
1999
|
2000
|
2001
|
2002
|
Total
|
|
Would never use
|
378
|
385
|
291
|
110
|
769
|
1933
|
|
Might Use
|
73
|
64
|
42
|
20
|
90
|
289
|
|
% Might Use
|
16.2%
|
14.3%
|
12.6%
|
15.4%
|
10.5%
|
13.0%
|
|
Age First Use
|
23.6
|
22.7
|
21.91
|
21.64
|
23.33
|
22.75
|
|
Rating out of 10
|
2.81
|
3.34
|
3.19
|
2.85
|
2.09
|
2.58
|
5.2 The
mean age of initiation is 22 years, 9 months, with a stable
or upward age trend. There is no evidence that younger
users are at increasing risk of being exposed to ketamine,
very few individuals had tried the drug before adulthood,
with most first trying ketamine between ages 18 and 30
(fig 4). The vast majority had first used ketamine between
1990 and 2000.
Fig
4-Age of First Ketamine Use (raw & cumulative)
5.3
A significant proportion of those having tried ketamine
claimed to have given up using the drug. Of those who
had not yet used ketamine, there was a 6:1 ratio between
those who stated they would never use the drug, and those
who might try it if offered.
6Attitudes
towards Ketamine
6.1Ketamine
has historically had a bad press among drug users,
in the 1970s Furry Freak Brothers comics it was
credited as causing a 12 hour nightmare (when sold as
bad LSD). Ketamines reputation among the drug subculture
is patchy, users generally give a negative rating (mean
2.58/10), with the majority giving it a zero, but
an even spread of attitudes among other responses (fig
5).
Fig
5 - Subjective Ratings of Ketamine

6.2 There
has been a decline in user ratings since 1999-the drug
appears to becoming less popular over time (table 4).
6.3 The
user-rating does vary significantly with frequency of
use (Table 5), the lowest ratings were given by those
who stated would never use the drug (1.18) the highest
(7.24) by regular (weekly/monthly but not daily) users.
|
Table
5 - Ketamine User-Ratings by frequency of/intention
to use
|
|
Frequency
|
Number
|
Mean User Rating
|
|
Would Never Use
|
962
|
1.18
|
|
Non User/blank
|
745
|
1.87
|
|
Ex-User
|
160
|
2.72
|
|
Might Use
|
135
|
4.16
|
|
Experimental
|
584
|
3.89
|
|
Occasional
|
134
|
5.80
|
|
Regular
|
89
|
7.24
|
|
Daily
|
15
|
3.73
|
7.
Ketamine prices
7.1
In many instances, a user will buy a ketamine tablet believing
it to be ecstasy, with ketamine/ephedrine/procaine tablets
very common during the 1990s. More recently, the advent
of over-the-counter ecstasy testing kits - available in
the UK since early 1998 - coupled with an interactive
web database and "users grapevine", has coincided
with an increase in the quality of ecstasy tablets (most
now contain MDMA, usually within range of 50-100mg), and
a reduced incidence of "fake" tablets containing
ketamine.
7.2
At the same time, a niche market has developed for ketamine
per se either in
tablet or powder form, such that the street price
of a tablet sold as ketamine is likely to exceed that
of a genuine ecstasy tablet (Table 6). At higher
levels of the market (10-100 tabs), tablet prices are
similar to those for ecstasy. No clear year on year price
trends are apparent, as the prices vary widely, with single
tablets/doses available from £2 to £20 each (fig 6)
|
Table
6 - Ketamine Price Trends 1998-2002
|
|
Year
|
1998
|
1999
|
2000
|
2001
|
2002
|
1998-02
|
|
Unit
|
n
|
mean
|
n
|
mean
|
n
|
mean
|
n
|
mean
|
n
|
mean
|
n
|
mean
|
|
Dose/Tab
|
0
|
n/a
|
73
|
£12.23
|
63
|
£10.37
|
21
|
£13.67
|
84
|
£10.93
|
241
|
£11.42
|
|
Gram/10tabs
|
38
|
£15.14
|
7
|
£35.71
|
6
|
£51.75
|
2
|
£100.00
|
7
|
£29.00
|
60
|
£25.65
|
|
Ounce/100 tabs
|
4
|
£212.50
|
1
|
£0.00
|
2
|
£300.00
|
1
|
£350.00
|
6
|
£176.67
|
14
|
£204.29
|
|
Ecstasy Tab
|
429
|
£9.46
|
541
|
£8.38
|
400
|
£6.99
|
111
|
£6.24
|
533
|
£5.47
|
2014
|
£7.45
|
Fig
6-Ketamine Price Distributions 1998-2002



8
Literature & Web Resources for Ketamine
8.1
There is a wealth of scientific references (over 6000)
relating to ketamine, mostly involving biochemical, toxicological
or veterinary aspects. In addition, there are over 2000
web pages with references to ketamine.
8.2 Ketamine
sold under its own right as K or Special K
re-emerged in the early 1990s among the rave subculture.
In an article for the Face magazine, McDermott[i] describes
the emergence of ecstasy and ketamine in the UK, then
ketamine was mainly obtained via medical supplies, although
ketamine tablets showed up as early as 1990, particularly
where ecstasy demand outstripped supply. He quotes one
user who took 3-4 tablets: "You
can't move, you can't think, you can't function -- all
you can do is experience". McDermott also
commented "Ketamine
is a damn sight easier to produce than Ecstasy - the precursor
chemicals are easier to get hold of, and because it isn't
illegal, you are unlikely to do time if you get caught.
So some unscrupulous drug dealers are still trying to
pass Ketamine off as "E". Others, no doubt working
on the basis that you can't fool all of the people, all
of the time, have thought ahead and worked out a clever
marketing strategy. ... In order to promote a rebirthing
mind-set, some "K" dealers are providing jars
of baby food and dummies". He also described
hospitalisations attributed to ketamine tablets, "people
who entered catatonic states after taking what they believed
were "E" but turned out to be K".
He did not consider that Ketamine would become a widespread
drug of abuse, "as
Ketamine lacks the euphoric and social properties that
led to the widespread use of MDMA, the drug is likely
to disappear as suddenly as it seems to have emerged".
8.3
Notable internet sites include the Erowid Ketamine Vault[ii], which includes users description of
experiences produced by doses of between 100mg and 250mg
intranasally (snorted) or via intramuscular injection.
These accounts range from the enthusiastic to negative
and cautionary. In particular, White[iii] reviews evidence of
NMDA antagonist neurotoxicity, with potential risks for
memory and cognitive function, and suggests use of GABA-ergic
drugs to counter neurotoxic effects, and avoidance of
drugs with known interactions which can increase the risk
(e.g. yohimbine, antipsychotics, anticholingergics, ecstasy
type drugs or hallucinogens, and monoamine oxidase inhibitors),
cautioning Ive
heard of far too many people who rolled the dice and lost
their sanity, their loved ones, their emotions and even
their lives. Lets try to keep this sort of thing to
a minimum . The risk of ketamine-induced neurodegeneration
has been raised in the British Medical Journal[iv]. . Other Erowid
links include research by MAPS (the multidisciplinary
association for psychedelic study) into the use of ketamine
in psychotherapy, including the management of alcohol
and opiate addiction. Their main Ketamine page had had
48000 hits in just over two years.
8.4 A
Plymouth drugs advice website[v]
notes the following "(Ketamine)
usually comes as a liquid in its pharmaceutical form (stolen
vets supplies will probably come in this form) although
it is also found as a white powder or pill. A wrap of
ketamine powder will cost between 6 and 25 pounds sterling
with the price varying widely with location and availability.
It can be either snorted or swallowed as a powder and
either swallowed or injected as a liquid. Injectors usually
inject into the muscles rather than a vein. Ketamine is
called "dissociative" in action, which means
that it feels as if the mind is "separated"
from the body. Ketamine causes hallucinations (the user
may feel as if they have entered another reality) and
as an anaesthetic stops the user feeling pain, which could
lead the user to cause unwitting injury to him or herself.
Ketamine does not depress respiratory functions. Ketamine
is a prescription only medicine and so is not covered
by the Misuse of Drugs Act. This means that possession
of ketamine is not a criminal offence. However, under
the Medicines Act unauthorised supply is illegal."
8.5
Another university-based Ketamine site[vi] gives the following advice:"Ketamine does not treat music so well. Expect
a narrowing of your auditory bandwidth. Music will sound
neat but not correct and not transcending. You will selectively
lose frequencies. Use mellow music with a psychedelic
flavour, and keep the volume less than loud because your
perception of overall volume will increase. Visual hallucinations
are most notable in low light. Touch is exceptional. Smells
and tastes will be nulled. Do not expect to talk, although
you may. Expect general reflection but not exceptional
emotionality. Oral Dose: A Line Dose is about 2.0 mg/lb.
body mass. Anaesthetic doses are above 4.0 mg/lb. A maximum
oral dose of 3 mg/lb. should be set for adequate recovery.
Above line dose, increasing doses yield little psychedelic
advantage except for greater temporary memory loss. A
good first dose is 300-350 mg for average weight woman,
and 350-375 mg for average weight men. A minimum dose
of 150-175 mg will give a good psychedelic experience.
IM Dose: Intramuscular doses begin at perhaps .4 mg/lb.
for a Line Dose. Anaesthetic doses to IM are about 1 mg/lb.
Two injections should be made instead of one. Sterility
of the bottle and needle are imperative. 100 mg seems
to be a good IM dose for everyone... IV Dose: I do not
recommend IV doses".
8.6 A
prevention-orientated US website[vii] and a UK-based youth culture website[viii]
both start their ketamine pages with the following advice:
"Ketamine is a short-acting general anaesthetic
that has hallucinogenic and painkilling qualities that
seem to affect people in very differently ways. Some people
describe a speedy rush within a few minutes of sniffing
the powder (20 minutes if taken as a pill), leading to
powerful hallucinations and even out of body experiences,
along with physical incapacitation. If you're on a dance
floor, music can sound heavy, weird and strangely compelling,
lights seem very intense and physical co-ordination can
fall apart along with an overall feeling of numbness.
Some people feel paralysed by the drug, unable to speak
without slurring, while others either feel sick or actually
throw up. Be extremely careful how much Ketamine you take
as it is stronger than the same amount of speed or coke.
Accept that you may well be in for a rough ride with the
drug as its effects are unpredictable and sometimes very
confusing. Try not to mix it with other drugs, particularly
alcohol. You may turn into a gibbering, spaced out bore,
mumbling and slurring away while your dancing may begin
to resemble Bill and Ben on acid. Your movements may become
as swift as a spliffed-up tortoise crawling across an
extra-sticky big bun on a very hot day. You may be unable
to move at all. "
8.7
Another UK website[ix]
states use in South
Yorkshire is still comparatively rare. The supply is thought
to come mainly from opportunistic thefts from vets premises
and vehicles. It usually comes as a liquid in its pharmaceutical
form (stolen vets supplies will probably come in this
form) although it is also found as a white powder or pill.
Some users are sold ketamine believing it to be ecstasy,
therefore its purchase and use is often around the "rave
scene".
8.8
A Florida based site[x]
states: Ketamine is
currently one of the most popular drugs among youths.
In the rave and club scene, the substance is often sold
under the name of "Special K" and is known as
"K", "KitKat", "Vitamin K",
and "Ket". The synthesis of ketamine is a complicated
multi-step process and to date the diversion of legitimate
product is the only known source for roughly 90% of the
quantity sold. This desire for ketamine has resulted in
an increase in animal hospital burglaries.
A South African Ravesafe site[xi] advises thus: "Physical
effects are loss of motor control (difficulty in walking,
standing and talking), temporary memory loss, numbness,
drowsiness, nausea. Ketamine is a strong drug which produces
an "out-of-body" experience: your mind dissociates
itself from your body. It blocks normal thinking, memory
recall and most sensory input. In the absence of external
input, the brain tends to fill the void with a "new
reality" - extreme hallucinations known as "emergence
phenomena". It's like you enter another world and
can't even see the people next to you. Ketamine causes
physical incapacition as well as very hard trips, and
is unlikely to make you want to dance."
8.9
The US government-backed Clearing House for Alcohol &
Drug information[xii] report Ketamine "
...is being abused by an increasing number of young people
as a "club drug," and is often distributed at
"raves" and parties. Some street names for ketamine
are: K, Ket, Special K, Vitamin K, Vit K, Kit Kat, Keller,
Kelly's day, Green, Blind squid, Cat valium, Purple, Special
la coke, Super acid, and Super C. Slang for experiences
related to ketamine or effects of ketamine include, "k-hole,"
"K-land," "baby food," and "God."
"The effects of a ketamine 'high' usually last
an hour but they can last for 4-6 hours, and 24-48 hours
are generally required before the user will feel completely
"normal" again."
8.10
At least one website was found where Ketamine can be purchased
over the internet[xiii], The India-based company
supplies 10ml vials containing 50mg ketamine for $2.00
each (minimum order 400) by international courier. Contraindications
are stated to be "Increased intracranial or intraocular pressure,
Psychiatric disorders. Cardiovascular disease such as
uncontrolled hypertension, unstable angina or recent myocardial
infarction, right or left heart failure, aneurysms.",and
dosage recommended as "i.v. route - Initial dose... 1 to 4.5 mg / kg
over a period of 1 minute. Maintenance dose - increments
of 50% of full induction dose repeatedly. i.m. route -
6.5 to 13 mg / kg.". Precautions listed
as"Rapid Injection
or overdosage may cause respiratory depression. Post operative
confusional states may occur. Periodic assessment of cardiovascular
functions. Alcohol Intoxicated patients. Increased CSF
and Intraocular pressure" . Side-effects
were listed as"Hypotension,
Increased BP / pulse rate, bradycardia, arrhythmia, respiratory
depression, illusions, vivid dreams, hallucinations diplopia,
nystagmus, clonic & tonic movements, anorexia, nausea,
vomiting.".
8.11
Karch[xiv] reports thus: "Recent reports from London, and from both coasts
of the United States, suggest that ketamine (known on
the streets as Special K), a close relative of phencyclidine
(PCP), has become the hot new club drug. There are no
published reports of toxicity in recreational users, perhaps
because when it is used as a recreational drug, it is
usually snorted in doses smaller than those used to produce
anesthesia in a hospital." "When used as an intravenous anesthetic in adults,
doses range from 1 to 4.5 mg/kg given over a period of
about one minute. Anesthesia can also be induced using
much higher doses (6.5 to 13 mg kg) via intramuscular
injection. When snorted by drug users, the dose, according
to street lore and reports on the Internet, is usually
50 to 100 mg."
9
Conclusions
9.1
Ketamine has most frequently been encountered by ecstasy
users in the club scene as fake tablets masquerading as
ecstasy. Since DIY pill testing kits were made available
the late 1990s the incidence of fake ecstasy tablets has
fallen, and the number of cases of accidental exposure
to ketamine would thus be expected to fall.
9.2
Intentional use of ketamine is largely confined to a niche
market among clubbers and others within the rave culture,
with possibly 30,000 users taking the drug on an occasional
or regular basis. The drug enjoys brief periods of publicity
where more individuals are likely to try the drug, although
only around one in four individuals who start taking ketamine
ever progress beyond experimental use. Those users who
have unpleasant experiences tend not to repeat the behaviour.
9.3
The general perception of ketamine among drug users as
a whole is negative, only a small minority of non-ketamine
users, who take other illicit drugs, would consider trying
Ketamine.
9.4
The user-ratings of ketamine are low, reflecting a low
probability of significantly increased usage, and appear
to be on a downward trend from a low baseline.
9.5
Prices of ketamine tablets are currently higher than those
of genuine ecstasy tablets, although at higher
market levels purchase prices are broadly equivalent.
9.6
It is accepted that ketamine can have profound psychological
effects on the recreational or unwitting user, however
it has been used as an anaesthetic for many years and
has, by all accounts, a good safety record.
10.
Recommendations
10.1
The current poor reputation of Ketamine among drug users
is the most effective deterrent to more widespread use.
Classifying ketamine as a controlled drug could risk glamourising
the drug, increasing the user-ratings, and the likelihood
of increased use.
10.2
Prevalence levels of ketamine use among drug users as
a whole are low, and are at worst stable, more probably
on a downward trend due to the reduced incidence of fake
ecstasy tablets. Where a person is found to offer ketamine
tablets as ecstasy (e.g. where tablets bear common ecstasy
logos), he or she can still be prosecuted for attempted
supply of a class A drug. There would appear to be no
imperative in favour of adding ketamine to the list of
controlled drugs at the present time.
10.3 Ketamine
has a number of legitimate applications in human and veterinary
medicine. The costs of added bureaucracy and safeguards
arising from classifying ketamine as a controlled drug
could have an adverse impact on the rural economy.
10.4
Note on GHB: IDMU has also been monitoring the
usage of gamma-hydroxybutyrate (GHB) since 1998, and have
baseline prevalence and attitudinal data in the years
leading up to prohibition of the substance in 2003. Our
2004 survey will be the first to monitor post-prohibition
attitudes-i.e. whether user ratings have decreased, increased
or been unaffected. Should prevalence or user-ratings
for GHB rise in the year following prohibition, it would
be reasonable to presume that a change in legislation
could have a similar effect on perceptions of ketamine.
10.5
It is therefore recommended that no action be taken in
respect of ketamine at the present time, and that the
effects on prevalence and attitudes of re-scheduling GHB
be reviewed when 2004 survey data becomes available (spring
2005), before any final decision on classification of
ketamine is taken.
Matthew
J Atha - Director
Simon
Davis-Research Co-ordinator
References
[i]
McDermott P (1992) Ketamine: Trick or treat? The Face
June 1992
[ii]
http://www.erowid.org/entheogens/ketamine
[iii]
White WE (1998) This is your brain on dissociatives:
The bad news is finally in. v0.1 28-11-98. http://www.frognet.net/~dxm/olney.html
[iv]
Shewan D, Dalgarno P (1996) Ecstasy and neurodegeneration.
...such as ketamine. BMJ 313(7054):424
[v]
http://area51.upsu.plym.ac.uk/~harl/ketamine.html
[vi]
http://orathost.cfa.ilstu.edu/classes/studentwork/pmmaher/public_html/keta2.htm
[vii]
http://xrules.com/drugs/ketamine.htm
[viii] http://www.urban75.com/Drugs/drugketa.html
[ix]
http://www.rickwilk.demon.co.uk/ketamine.htm
[x]
http://207.100.97.5/OSI/Drug_Alerts/
[xi]
http://www.pcb.co.za/users/ravesafe/ketamine.htm
[xii]
http://www.health.org/pubs/qdocs/ketamine/ketafact.htm
[xiii] http://www.bicserve.com/htm/ketotal1.htm
[xiv] Karch
SB (1997) Ketamine: the hot new drug of abuse. Forensic
Drug Abuse Advisor 9(6), cited at http://www.inform.umd.edu/EdRes/Colleges/BSOS/Depts/Cesar/drugs/KETA-ART.HTML